NCT03541122

Brief Summary

Acetabular dysplasia often accompanies by acetabular bone hyperplasia and osteonecrosis of the femoral head. These pathological changes can alter the position of the center of the femoral head. Thus, measurement errors will be generated on the anteroposterior radiographs of the adult pelvis involving centre-edge angle, acetabular angle (Sharp angle), and acetabular head index, eventually resulting in the inaccurate diagnosis of acetabular dysplasia. Herein, the investigators describe the protocol to verify three novel X-ray indicators, including offshoring index (OFI), moving up index (MUI) and teardrop baseline offshoring index (TBOI) of the femoral head. All data will be expressed as relative ratios, as the investigators expect to make an accurate diagnosis through avoiding the generation of errors resulting from measurement angles.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2018

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 17, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 30, 2018

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

May 30, 2018

Status Verified

May 1, 2018

Enrollment Period

1.7 years

First QC Date

May 17, 2018

Last Update Submit

May 17, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • The sensitivity of offshoring index (OFI)

    The sensitivity represents the percentage of actual patients who are correctly diagnosed with a disease. A higher sensitivity indicates a higher rate of correct diagnosis for acetabular dysplasia.

    One day after hospitalization

Secondary Outcomes (5)

  • The specificity of OFI,MUI and TBOI

    One day after hospitalization

  • The positive predictive value of OFI,MUI and TBOI

    One day after hospitalization

  • The negative predictive value of OFI,MUI and TBOI

    One day after hospitalization

  • The positive likelihood ratio of OFI,MUI and TBOI

    One day after hospitalization

  • The negative likelihood ratio of OFI,MUI and TBOI

    One day after hospitalization

Study Arms (1)

Experimental group

Patients will undergo pelvic X-ray examinations. Measurement indicators will include OFI, MUI, TBOI, CE angle, Sharp angle and AHI of the affected and healthy femoral heads. The investigators will determine the sensitivity and specificity of OFI, MUI and TBOI for the diagnosis of adult acetabular dysplasia, and compare the accuracy of diagnosis between these three indicators and CE angle, sharp angle, and AHI. Further analysis of risk factors for hip function will be implemented.

Diagnostic Test: pelvic X-ray examinations

Interventions

Measurement indicators will include OFI, MUI, TBOI, CE angle, Sharp angle and AHI of the affected and healthy femoral heads.

Experimental group

Eligibility Criteria

Age16 Years+
Sexall(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Potential patients will be informed of the study details through an announcement issued through the bulletin board of the Third Hospital of Hebei Medical University. Interested patients will directly contact the principle investigator via telephone, and among them, eligible patients will be required to provide written consent prior to the participation in the trial.

You may qualify if:

  • No experience in hip replacement, pelvic fixation or external fixation, and proximal femoral surgery;
  • No marked pelvic tilt;
  • No hip dislocation;
  • No obvious hip deformity, such as significant collapse of the femoral head and severe hip traumatic arthritis;
  • No significant lesions in the pelvis or proximal femur;
  • Aged over 16 years;
  • Provision of written informed consent.

You may not qualify if:

  • Those with advanced osteoarthritis;
  • Those with osteoarthritis secondary to acetabular dysplasia;
  • Those with ankylosing spondylitis involving the hip joint;
  • Those with rheumatoid arthritis;
  • Those with inflammatory inflammation of the hip joint;
  • Those with tumor lesions in the hip joint.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Third Hospital of Hebei Medical University

Shijiazhuang, Hebei, 050051, China

Location

MeSH Terms

Conditions

Hip Dislocation

Condition Hierarchy (Ancestors)

Joint DislocationsJoint DiseasesMusculoskeletal DiseasesWounds and InjuriesHip Injuries

Study Officials

  • Di Qin, M.S.

    Third Hospital of Hebei Medical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 17, 2018

First Posted

May 30, 2018

Study Start

February 1, 2018

Primary Completion

October 1, 2019

Study Completion

December 1, 2019

Last Updated

May 30, 2018

Record last verified: 2018-05

Locations